• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体中被动转移抗体留存情况的研究。II. 静脉或肌肉注射抗乙肝表面抗原人免疫球蛋白后血液中的抗体活性

Studies on the retention of passively transferred antibodies in man. II. Antibody activity in the blood after intravenous or intramuscular administration of anti-HBs human immunoglobulin.

作者信息

Shibata Y, Baba M, Kuniyuki M

出版信息

Vox Sang. 1983;45(1):77-82. doi: 10.1111/j.1423-0410.1983.tb04126.x.

DOI:10.1111/j.1423-0410.1983.tb04126.x
PMID:6880149
Abstract

Catabolism of intravenously or intramuscularly administered human immunoglobulin in man was studied by the administration of HBs antibodies at a high titer and analysis with a highly sensitive radioimmunoassay technique. The half-life in the blood of the antibodies in the aggregate-reduced antibody preparation administered intravenously was found to be 17.7 days and of those in the antibody preparation administered intramuscularly to be 23.8 days.

摘要

通过给予高滴度的乙肝表面抗体(HBs抗体)并采用高灵敏度放射免疫分析技术进行分析,对人体中静脉内或肌肉内注射的人免疫球蛋白的分解代谢进行了研究。结果发现,静脉注射的聚合体减少型抗体制剂中抗体在血液中的半衰期为17.7天,而肌肉注射的抗体制剂中抗体的半衰期为23.8天。

相似文献

1
Studies on the retention of passively transferred antibodies in man. II. Antibody activity in the blood after intravenous or intramuscular administration of anti-HBs human immunoglobulin.人体中被动转移抗体留存情况的研究。II. 静脉或肌肉注射抗乙肝表面抗原人免疫球蛋白后血液中的抗体活性
Vox Sang. 1983;45(1):77-82. doi: 10.1111/j.1423-0410.1983.tb04126.x.
2
Studies on the retention of passively transferred antibodies in man. I. Quantitative measurement of the antibody activities to HBs by radioimmunoassay and its application to studies on the blood level of intravenously administered 7 S or 5 S antibody.
Vox Sang. 1982;43(4):205-11. doi: 10.1111/j.1423-0410.1982.tb00013.x.
3
Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation.静脉注射或肌肉注射抗乙肝表面抗体免疫球蛋白用于预防原位肝移植后乙肝再感染。
Transplantation. 1997 Feb 15;63(3):478-80. doi: 10.1097/00007890-199702150-00027.
4
[Uptake and elimination of hepatitis B immunoglobulin after intramuscular administration].[肌内注射后乙肝免疫球蛋白的摄取与消除]
Dtsch Med Wochenschr. 1982 Dec 17;107(50):1918-22. doi: 10.1055/s-2008-1070233.
5
Uptake and elimination of hepatitis B immunoglobulins after intramuscular application in man.人肌肉注射乙型肝炎免疫球蛋白后的摄取与消除
Dev Biol Stand. 1983;54:347-55.
6
Passive-active immunization after anti-HBs immunoglobulin?
JAMA. 1981 Oct 2;246(14):1546-7. doi: 10.1001/jama.1981.03320140034018.
7
Intravenous immunoglobulin: a review.静脉注射免疫球蛋白:综述
Immunodefic Rev. 1989;1 Suppl:1-42.
8
Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.肌内注射与低剂量皮内注射乙型肝炎疫苗。通过对乙型肝炎表面抗原的体液和细胞免疫反应进行评估。
Med J Aust. 1987 Mar 2;146(5):242-5.
9
Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.肝移植后静脉注射和肌肉注射乙肝免疫球蛋白后,乙肝表面抗原抗体谷浓度和半衰期并无差异。
Liver Transpl. 2008 Apr;14(4):435-42. doi: 10.1002/lt.21343.
10
Pharmacokinetic studies of passively administered ovine anti-testosterone antibodies given to cattle by the subcutaneous and intravenous routes.通过皮下和静脉途径给牛被动注射羊抗睾酮抗体的药代动力学研究。
Immunology. 1990 Apr;69(4):603-9.

引用本文的文献

1
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.多克隆高免疫球蛋白:一种经过验证的被动免疫治疗和预防平台,可用于应对现有和新出现的疾病。
Hum Vaccin Immunother. 2022 Apr 29;18(2):1886560. doi: 10.1080/21645515.2021.1886560. Epub 2021 May 19.
2
Pharmacokinetic characteristics and tolerability of a novel intravenous immunoglobulin preparation.一种新型静脉注射免疫球蛋白制剂的药代动力学特征及耐受性
Eur J Clin Pharmacol. 1995;49(3):237-42. doi: 10.1007/BF00192385.